AZD5991

Overview

AZD5991 is an Mcl-1 inhibitor being tested in multiple myeloma.

SparkCures ID 292
Developed By AstraZeneca
Generic Name AZD5991
Treatment Classifications

Clinical Trials

Resources

There are no resources, links or videos to display for this treatment.